Survivin(g) adult T-cell leukemia/lymphoma.
Janik
John E
JE
Clinical Trials Team, Metabolism Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
Morris
John C
JC
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D005260:Female; D020869:Gene Expression Profiling; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000188:drug therapy* / Q000235:genetics / Q000628:therapy*; D008297:Male; D008869:Microtubule-Associated Proteins / Q000235:genetics* / Q000378:metabolism; D000077022:Survivin; D014184:Transplantation, Homologous
C107489:BIRC5 protein, human; D051034:Inhibitor of Apoptosis Proteins; D008869:Microtubule-Associated Proteins; D000077022:Survivin